Primary record
2H-(1,6)DIOXACYCLOUNDECINO(2,3,4-GH)PYRROLIZINE-2,6(3H)-DIONE, 4,5,8,10,12,13,13A,13B-OCTAHYDRO-4,5-DIHYDROXY-3,4,5-TRIMETHYL-, (3R-(3R*,4R*,5R*,13AR*,13BR*))-
- 库存
- 5,403 克
- 纯度
- 98.3 %
- CAS
- 315-22-0
化合物标识与属性
- CAS
- 315-22-0
- PubChem CID
- 9415
- SMILES
- C[C@H]1C(=O)O[C@@H]2CCN3[C@@H]2C(=CC3)COC(=O)[C@]([C@]1(C)O)(C)O
- Canonical SMILES
- C[C@H]1C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@](C)(O)[C@]1(C)O)[C@H]23
名称与同义词
- monocrotaline
- Crotaline
- Monocrotalin
- 315-22-0
- Testosterone oenanthate
- (-)-Monocrotaline
- Mono crotoline
- Prestwick_338
- MONOCRATALINE
- Pyrrolizidine alkaloid
- Spectrum_001224
- CCRIS 416
- NCI-C56462
- Monocrotaline Impurity 2
- AC1L1SZM
- 2-Fluoro-4-iodopyridine
- Prestwick0_000603
- Prestwick1_000603
- Prestwick2_000603
- Prestwick3_000603
- RefChem:159547
- Spectrum2_000906
- Spectrum3_000947
- Spectrum4_001057
- Spectrum5_001233
- CHEBI:6980
- DTXSID9020902
- MONOCROTALINE [MI]
- NSC 28693
- D0G6AB
- DTXCID50902
- HSDB 3513
- UNII-73077K8HYV
- MLS002153902
- QVCMHGGNRFRMAD-XFGHUUIASA-N
- 73077K8HYV
- MONOCROTALINE [HSDB]
- MONOCROTALINE [IARC]
- MFCD00084656
- BSPBio_000506
- dihydroxy(trimethyl)[?]dione
- KBioGR_001354
- KBioSS_001704
- C16H23NO6
- DivK1c_000959
- SCHEMBL164486
- SPECTRUM1502252
- SPBio_000752
- SPBio_002725
- NSC-28693
- BPBio1_000558
- CHEMBL521035
- MEGxp0_001899
- ACon0_000305
- ACon1_000179
- ERK5-6A12
- HMS502P21
- KBio1_000959
- KBio2_001704
- KBio2_004272
- KBio2_006840
- KBio3_002014
- BRN 0048732
- CID9415
- Monocrotaline, analytical standard
- NINDS_000959
- A 6080
- HMS1569J08
- HMS1921P04
- HMS2096J08
- HMS2235J12
- HY-N0750
- MSK14173
- NCI-C-56462
- NSC28693
- Tox21_112094
- Tox21_201509
- Tox21_302874
- BDBM50480309
- C16-H23-N-O6
- CCG-39621
- EBD583340
- NCGC00164256-01
- s3812
- Tetrabutylammonium hexafluorophosphate
- ZINC53195720
- AKOS015969712
- AKOS032962048
- Tox21_112094_1
- ACN-047141
- CS-6164
- FM64904
- FS-5652
- LS-7530
- MONOCROTALINE (REFERENCE GRADE)
- Retronecine cyclic 2,3-dihydroxy-2,3,4-trimethylglutarate
- SDCCGMLS-0066675.P001
- IDI1_000959
- NCGC00179538-01
- NCGC00179538-02
- NCGC00179538-03
- NCGC00256518-01
- NCGC00259060-01
- NCGC00262539-03
- AC-34918
- CAS-315-22-0
- SMR001233251
- SY065743
- AB0109458
- J107.104A
- FT-0777497
- N1470
- (13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione
- 4-27-00-06660 (Beilstein Handbook Reference)
- 14,19-Dihydro-12,13-dihydroxy-20-norcrotolanan-11,15-dione
- C10350
- JACS 72: 158 (1950)
- A856086
- F002602
- SR-01000838886
- 12-beta,13-beta-Dihydroxy-12-alpha,13-alpha,14-alpha-trimethylcrotal-1-enine
- SR-01000838886-3
- SR-01000838886-4
- 14,19-Dihydro-12,13-dihydroxy(13-alpha,14-alpha)-20-norcrotalanan-11,15-dione
- 20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13alpha,14alpha)-
- BRD-K65508953-001-05-5
- BRD-K65508953-001-08-9
- Q27107379
- (1R,4R,5R,6R,16R)-5,6-dihydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione
- (3R,4R,5R,13aR,13bR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
- (3R,4R,5R,8a1R,13aR)-4,5-Dihydroxy-3,4,5-trimethyl-4,5,8,8a1,10,12,13,13a-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
- (2,3,4-gh)pyrrolizine-2,6(3H)-dione, (4,5,8,10,12,13,13a,13b)-octahydro-4,5-dihydroxy-3,4,5-trimethyl-2H-(1,6)dioxacycloundecino-
- 2H-(1,6)Dioxacycloundecino(2,3,4-gh)pyrrolizine-2,6(3H)-dione, 4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-, (3R,4R,5R,13aR,13bR)-
- 20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13-alpha,14-alpha)-
- 20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-
- (13R,14R)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione
- (3R,4R,5R,13aR,13bR)-4,5,8,10,12,13,13a,13b-Octahydro-4,5-dihydroxy-3,4,5-trimethyl-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
- 2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione, 4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-, (3R,4R,5R,13aR,13bR)-
- Crotaline, 98%, from Lilium brownii F.E.Br. ex Miellez - 10MG 10mg
- (13-alpha,14-alpha)-14,19-dihydro-12,13-dihydroxy-20-norcrotolanan-11,15-dione
- (13|A,14|A)-14,19-dihydro-12,13-dihydroxy-20-Norcrotalanan-11,15-dione
- (1R,4R,5R,6R,16R)-5,6-dihydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0??,??]hexadec-10-ene-3,7-dione
- (3R,4R,5R,13aR,13bR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-(1,6)dioxacycloundecino(2,3,4-gh)pyrrolizine-2,6(3H)-dione
- (3R,4R,8a1R,13aR)-4,5-Dihydroxy-3,4,5-trimethyl-4,5,8,8a1,10,12,13,13a-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
- (3S,4S,5R,13aR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
- 109525-74-8
- 2H-(1,6)DIOXACYCLOUNDECINO(2,3,4-GH)PYRROLIZINE-2,6(3H)-DIONE, 4,5,8,10,12,13,13A,13B-OCTAHYDRO-4,5-DIHYDROXY-3,4,5-TRIMETHYL-, (3R-(3R*,4R*,5R*,13AR*,13BR*))-
- 2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-,(3R,4R,5R,13aR,13bR)-
- rel-(3R,4R,5R,8a1R,13aR)-4,5-Dihydroxy-3,4,5-trimethyl-4,5,8,8a1,10,12,13,13a-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione